• No image available for this medication

    • RINVOQ

    • QTY 30
    • 15 MG
    • Tablet ER 24H

UPADACITINIB (ue PAD a SYE ti nib) treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and ankylosing spondylitits. It is also used to treat ulcerative colitis. It works on the immune system. It belongs to a group of medications called JAK inhibitors.

RINVOQ Lifestyle Interactions

  • Upadacitinib 15mg, Oral tablet, extended release

    • Interaction: Grapefruit juice
    • Severity: Moderate
    • Notes for Consumers: It is best to avoid taking Upadacitinib with grapefruit juice and to avoid grapefruit juice completely during your Upadacitinib treatment. Grapefruit juice may increase the levels of Upadacitinib and the risk for side effects from your treatment.
    • Notes for Professionals: The exposure to upadacitinib, CYP3A4 substrate may be significantly increased in patients who regularly consume grapefruit or grapefruit juice, a strong CYP3A4 inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.